0.61
+0.0071(+1.17%)
Currency In USD
| Previous Close | 0.61 |
| Open | 0.62 |
| Day High | 0.63 |
| Day Low | 0.6 |
| 52-Week High | 1.82 |
| 52-Week Low | 0.2 |
| Volume | 189,572 |
| Average Volume | 1.45M |
| Market Cap | 63.54M |
| PE | -1.33 |
| EPS | -0.46 |
| Moving Average 50 Days | 0.67 |
| Moving Average 200 Days | 0.6 |
| Change | 0.01 |
If you invested $1000 in Unicycive Therapeutics, Inc. (UNCY) since IPO date, it would be worth $122.44 as of February 05, 2025 at a share price of $0.612. Whereas If you bought $1000 worth of Unicycive Therapeutics, Inc. (UNCY) shares 3 years ago, it would be worth $460.3 as of February 05, 2025 at a share price of $0.612.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in the Journal of Nephrological Science
GlobeNewswire Inc.
Jan 28, 2025 12:00 PM GMT
Large pill size, high pill burden and palatability were identified as key barriers for phosphate binder adherenceLOS ALTOS, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology compan
Unicycive Therapeutics Announces Publication of Positive Oxylanthanum Carbonate (OLC) Dose Escalation Data in Clinical and Translational Science
GlobeNewswire Inc.
Jan 07, 2025 12:00 PM GMT
LOS ALTOS, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that data
Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics
GlobeNewswire Inc.
Dec 17, 2024 12:00 PM GMT
LOS ALTOS, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that data